DR info

Clinical trials : 98 / Drugs : 108 - (DrugBank : 28) / Drug target genes : 22 - Drug target pathways : 81

Wegener granulomatosis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
44	Wegener granulomatosis
46	Malignant rheumatoid arthritis
51	Scleroderma
43	Microscopic polyangiitis
11	Myasthenia gravis
96	Crohn disease
53	Sjogren syndrome
49	Systemic lupus erythematosus
13	Multiple sclerosis/Neuromyelitis optica
45	Eosinophilic granulomatosis with Polyangiitis
84	Sarcoidosis
41	Giant cell arteritis
97	Ulcerative colitis
271	Ankylosing spondylitis
50	Dermatomyositis
40	Takayasu arteritis
65	Primary immunodeficiency
162	Pemphigoid
42	Polyarteritis nodosa
93	Primary biliary cholangitis
107	Juvenile idiopathic arthritis
222	Primary nephrotic syndrome
60	Aplastic anemia
284	Diamond-Blackfan anemia
300	IgG4-related disease
285	Fanconi anemia
55	Relapsing polychondritis
19	Lysosomal storage disease
256	Muscle glycogenosis
164	Oculocutaneous albinism
283	Acquired pure red cell aplasia
62	Paroxysmal nocturnal hemoglobinuria
35	Pemphigus
85	Idiopathic interstitial pneumonia
66	IgA nephropathy
95	Autoimmune hepatitis
226	Interstitial cystitis with Hunners ulcer
268	Nakajo-Nishimura syndrome
325	Hereditary autoinflammatory syndrome
61	Autoimmune hemolytic anemia
331	Idiopathic multicentric castleman disease
228	Bronchiolitis obliterans
56	Behcet disease
269	Pyogenic arthritis
94	Primary sclerosing cholangitis
172	Hypophosphatasia
2	Amyotrophic lateral sclerosis
6	Parkinson disease
10	Charcot-Marie-Tooth disease
14	Chronic inflammatory demyelinating polyneuropathy
36	Epidermolysis bullosa
298	Hereditary pancreatitis
54	Adult still disease
52	Mixed connective tissue disease
220	Rapidly progressive glomerulonephritis
30	Distal myopathy